Projects per year
Abstract
BACKGROUND: Blood pressure variability (BPV) in midlife increases risk of late-life dementia, but the impact of BPV on the cognition of adults who have already reached older ages free of major cognitive deficits is unknown. We examined the risk of incident dementia and cognitive decline associated with long-term, visit-to-visit BPV in a post hoc analysis of the ASPREE (Aspirin in Reducing Events in the Elderly) trial. METHODS AND RESULTS: ASPREE participants (N=19 114) were free of dementia and significant cognitive impairment at enrollment. Measurement of BP and administration of a standardized cognitive battery evaluating global cognition, delayed episodic memory, verbal fluency, and processing speed and attention occurred at baseline and follow-up visits. Time-to-event analysis using Cox proportional hazards regression models were used to calculate hazard ratios (HR) and corresponding 95% CI for incident dementia and cognitive decline, according to tertile of SD of systolic BPV. Individuals in the highest BPV tertile compared with the lowest had an increased risk of incident dementia and cognitive decline, independent of average BP and use of antihypertensive drugs. There was evidence that sex modified the association with incident dementia (interaction P=0.02), with increased risk in men (HR, 1.68; 95% CI, 1.19-2.39) but not women (HR, 1.01; 95% CI, 0.72-1.42). For cognitive decline, similar increased risks were observed for men and women (interaction P=0.15; men: HR, 1.36; 95% CI, 1.16-1.59; women: HR, 1.14; 95% CI, 0.98-1.32). CONCLUSIONS: High BPV in older adults without major cognitive impairment, particularly men, is associated with increased risks of dementia and cognitive decline.
Original language | English |
---|---|
Article number | e019613 |
Number of pages | 21 |
Journal | Journal of the American Heart Association |
Volume | 10 |
Issue number | 13 |
DOIs | |
Publication status | Published - 6 Jul 2021 |
Keywords
- Blood pressure
- Blood pressure variability
- Cognitive impairment
- Dementia
Projects
- 2 Finished
-
ASPREE Completion Project
McNeil, J., Nelson, M., Tonkin, A. & Woods, R.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/16 → 31/12/18
Project: Research
-
A randomised double-blind placebo-controlled trial of aspirin in primary prevention of CVD events or dementia in the aged ID: 334047
McNeil, J., Beilin, L. J., Krum, H., Nelson, M., Reid, C. & Tonkin, A.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/05 → 31/12/09
Project: Research